Lowe Brockenbrough & Co’s Boston Scientific BSX Stock Holding History

Lowe Brockenbrough & Co’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,035	Closed	-$289K	–	330
2025 Q4	$289K	Sell	3,035 -175	-5%	-$17.2K	0.01%	256
2025 Q3	$313K	Hold	3,210	–	–	0.02%	252
2025 Q2	$345K	Buy	+3,210	New	+$325K	0.02%	237
2024 Q3	–	Sell	-3,012	Closed	-$232K	–	267
2024 Q2	$232K	Hold	3,012	–	–	0.02%	253
2024 Q1	$206K	Buy	+3,012	New	+$194K	0.01%	259
2021 Q4	–	Sell	-5,600	Closed	-$243K	–	257
2021 Q3	$243K	Buy	+5,600	New	+$248K	0.02%	253

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Lowe Brockenbrough & Co's BSX Position: Q1 2026 in Review

Lowe Brockenbrough & Co sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 3,035 shares — an estimated $289K sold.

Lowe Brockenbrough & Co first reported a position in BSX in Q3 2021 and held it in 6 quarters. The position peaked at $345K in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Lowe Brockenbrough & Co reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
Lowe Brockenbrough & Co sold 3,035 Boston Scientific shares in Q1 2026, an estimated $289K.
Lowe Brockenbrough & Co first reported a position in Boston Scientific in Q3 2021 and held it in 6 quarters.
Lowe Brockenbrough & Co's Boston Scientific position peaked at $345K in Q2 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Lowe Brockenbrough & Co's 13F filing for Q1 2026, filed 7 May 2026.